Global Chronic Disease Management/Self-Monitoring Market Report 2021: Disruptive Self-Disease Management Platforms Are Enabling Better Clinical Outcomes in Chronic Illnesses.

Global Chronic Disease Management/Self-Monitoring Market Report 2021: Disruptive Self-Disease Management Platforms Are Enabling Better Clinical Outcomes in Chronic Illnesses.

GlobeNewswire

Published

Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Emerging Technology Innovations and Growth Opportunities Enabling the Self-Monitoring of Health: The Way to Healthcare Consumerism" report has been added to *ResearchAndMarkets.com's* offering.

This research service analyzes the challenges associated with the traditional care delivery model and the advantages of self-monitoring technologies in chronic disease management.

It explores the various emerging technologies that enable self-chronic disease management and the companies to action. The technological voids and the design considerations for consumer products are also investigated.

Self-health monitoring products and technologies boost consumer awareness of their health and help them to monitor it, avail timely medical help, and lead a high-quality life.

Tools such as wearables, body patches, smartphone applications, lateral flow assays, and other peripheral devices are used to diagnose acute conditions, help patients reach their wellness goals, or self-manage their medical conditions. Self-monitoring is crucial for patients suffering from chronic conditions as continuous monitoring is essential to identify personal risk factors and lifestyle management to prevent the exacerbation of the condition.

Chronic diseases are a major risk factor for severe illness with COVID-19, and the limited access to healthcare systems due to lockdowns is leading to increased awareness and use of self-use medical devices and mobile healthcare applications for condition management. Healthcare consumers measure and track their health regularly, set personal health goals, and make lifestyle changes accordingly.

The COVID-19 pandemic is having a profound impact on healthcare consumer behavior and is enabling the growth of the self-monitoring health industry. Self-monitoring products are available in diverse platforms, and the key industry participants leverage advancements in AI, IoT, mHealth, sensor technologies, and disruptive technologies such as flexible sensors and flexible microfluidics for their consumer health products.

The growth drivers and the restraints in the self-monitoring health industry are examined, and the growth opportunities offered by smart home technologies, sweat sensors and interstitial fluid sensors, and cancer care are discussed. Strategic recommendations for key participants are put forth, and the study also includes an IP landscape analysis of the patents filed over the past 6 years.

*Key Topics Covered:*

*1.0 Strategic Imperatives*
1.1 The Strategic Imperative: Factors creating Pressure on Growth in the Self-Monitoring Health Industry
1.2 The Strategic Imperative
1.3 The Impact of the Top Three Strategic Imperatives on the Self-Monitoring Health Industry
1.4 About the Growth Pipeline Engine
1.5 Growth Opportunities Fuel the Growth Pipeline Engine

*2.0 Research Context*
2.1 Research Context: Key Questions the Research Will Answer
2.2 Research Methodology
2.3 Key Findings

*3.0 Technology Snapshot*
3.1 Self-monitoring Tools Enable Acute Disease Diagnosis, Chronic Condition Management, and Fitness Monitoring
3.2 The COVID-19 Pandemic is Having a Profound Impact on Healthcare Consumer Trends
3.3 Traditional Chronic Illness Care Delivery is Not Easily Accessible
3.4 Self-monitoring of Chronic illnesses can Benefit both Patients and Physicians
3.5 Flexibility, Ease of Use, Sturdiness, and Other Vital Design Considerations for Self-use Devices
3.6 Technology for the Self-monitoring of Chronic Diseases can be Segmented based on Platform Type
3.7 The Technological Voids in Cancer Self-care and At-home Diagnostic Assays Must be Addressed

*4.0 Industry Overview and Assessment*
4.1 Impact Mapping of Growth Drivers and Restraints
4.2 The Prevalence of Chronic Diseases Will Drive Industry Growth
4.3 The Risk of Development of Mental and Behavioral Disorders in Patients Can Restrain Industry Growth

*5.0 Technology Profiles*
5.1 Technology Segment: Wearables for Self-Chronic Disease Management
5.1.1 AI-based Headband to Detect Neurological Injuries
5.1.2 Wearable Wristband that Enables the Real-time Monitoring of Oxygen Saturation, Respiration, and Heart Rate
5.2 Technology Segment: Vital Sign Monitoring for Self-Chronic Disease Management
5.2.1 Pocket Six-lead Electrocardiogram Device for Arrhythmia Detection
5.2.2 Home-use Kit of Wireless Digital Medical Devices for Self-cardiac Health Monitoring
5.3 Technology Segment: At-Home Diagnostic Assays for Self-Chronic Disease Management
5.3.1 Rapid At-home Diagnostic Test for Chronic Kidney Disease
5.3.2 Smart Glucose Meter and Expert Coaching for Diabetes Management
5.4 Technology Segment: Mobile Applications for Self-Chronic Disease Management
5.4.1 AI-powered Video-based Health Monitoring Mobile Application
5.4.2 Application for Personalized Behavioral Health Management

*6.0 Intellectual Property Landscape*
6.1 The Key Innovation Themes of IP Activity Include Blood Glucose Monitoring and Analyte Sensors
6.2 Key Patents

*7.0 Growth Opportunity Universe*
7.1 Growth Opportunity 1: Smart Home Technologies to Empower the Elderly and Chronically Ill Patients
7.2 Growth Opportunity 2: Sweat Sensors and Interstitial Fluid Sensors for Non-invasive Analyte Measurement
7.3 Growth Opportunity 3: Self-monitoring Technologies for Cancer Care Enable Diagnosis of At-risk Patients and Cancer Survivors
7.4 Key Conclusions and Strategic Recommendations

*8.0 Key Industry Participants*
8.1 Database of Key Industry Participants

*9.0 Appendix*
9.1 Reference for Technology Readiness level

*10.0 Your Next Steps*

For more information about this report visit https://www.researchandmarkets.com/r/b5ese9

CONTACT: CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Full Article